NAVI
50
-5
HSIC
56
-3
PBI
63
-3
EQR
47
-6
BDX
52
-2
BXP
50
-4
D
43
-2
LLY
57
4
HON
64
-4
GD
44
3
ADM
33
-4
VRSN
58
-2
PRU
62
-2
MTCH
55
2
UPS
51
-7
WM
76
-3
DE
62
-3
SO
51
-4
URBN
82
2
CPB
30
-9
NAVI
50
-5
HSIC
56
-3
PBI
63
-3
EQR
47
-6
BDX
52
-2
BXP
50
-4
D
43
-2
LLY
57
4
HON
64
-4
GD
44
3
ADM
33
-4
VRSN
58
-2
PRU
62
-2
MTCH
55
2
UPS
51
-7
WM
76
-3
DE
62
-3
SO
51
-4
URBN
82
2
CPB
30
-9
Financhill
Back

Biomarin Pharmaceutical Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
58

BMRN
Biomarin Pharmaceutical

Last Price:
66.53
Seasonality Move:
10.41%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
254.76
Seasonality Move:
7.55%
Buy
58
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.19. The Score for BMRN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $251.84. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.19
    The current trend is relatively stagnant and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $251.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.17 Sell
Relative Strength Index (14 RSI): 36.92 Sell
Chaikin Money Flow: -1147871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.54 - 67.12) Sell
Bollinger Bands (100): (66.53 - 86.51) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.1 Sell
Relative Strength Index (14 RSI): 43.24 Sell
Chaikin Money Flow: 214051 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (245.03 - 274.53) Sell
Bollinger Bands (100): (248.53 - 281.65) Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.67 Sell
20-day SMA: 64.91 Sell
50-day SMA: 67.58 Sell
200-day SMA: 80.37 Sell
8-day EMA: 64.54 Sell
20-day EMA: 65.25 Sell
50-day EMA: 68.71 Sell
200-day EMA: 78.54 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 250.96 Buy
20-day SMA: 255.88 Sell
50-day SMA: 270.14 Sell
200-day SMA: 214.29 Buy
8-day EMA: 251.71 Buy
20-day EMA: 256.34 Sell
50-day EMA: 262.6 Sell
200-day EMA: 232.29 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):